These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11511570)

  • 21. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts.
    Takahashi M; Katayama Y; Takada H; Kuwayama H; Terano A
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():44-9. PubMed ID: 10807402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.
    Wallace JL; Bak A; McKnight W; Asfaha S; Sharkey KA; MacNaughton WK
    Gastroenterology; 1998 Jul; 115(1):101-9. PubMed ID: 9649464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ„ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing.
    Peskar BM
    Inflammopharmacology; 2005; 13(1-3):15-26. PubMed ID: 16259725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complications.
    Chan FK
    Curr Pharm Des; 2003; 9(27):2213-9. PubMed ID: 14529402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New NSAIDs and gastroduodenal damage.
    Folco GC
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats].
    Shen X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice.
    Darling RL; Romero JJ; Dial EJ; Akunda JK; Langenbach R; Lichtenberger LM
    Gastroenterology; 2004 Jul; 127(1):94-104. PubMed ID: 15236176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal repair and COX-2 inhibition.
    Perini RF; Ma L; Wallace JL
    Curr Pharm Des; 2003; 9(27):2207-11. PubMed ID: 14529401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2].
    Tada Y; Nagasawa K
    Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum.
    Cryer B
    Gastroenterol Clin North Am; 2001 Dec; 30(4):877-94, v-vi. PubMed ID: 11764533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors].
    Bannwarth B; Berenbaum F
    Rev Med Interne; 1999 Aug; 20 Suppl 3():341s-345s. PubMed ID: 10480184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of non-steroidal anti-inflammatory drug-gastropathy.
    Fiorucci S; Antonelli E; Morelli A
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S35-43. PubMed ID: 11827361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.